Researchers have unpicked the mechanism behind a marine feeding strategy that could provide a valuable renewable source of biofuel.
Their research has been published as a Reviewed Preprint in eLife, with the revised version appearing today. It is described by the editors as an important study providing convincing evidence on how the sea slug Aplysia kurodai optimises its digestion of brown algae, in a classical predator-prey 'arms race' at the molecular level. The authors’ findings are supported by experimental protein structures and enzyme assays and hold promise for biotechnological applications in biofuel production.
Over millions of years, predators have successfully co-evolved with their prey to maintain an ecological balance. In marine habitats, interactions between algae and marine herbivores dominate marine ecosystems, with most algae being consumed by herbivores.
The feeding strategy of the sea slug Aplysia kurodai has attracted attention because when it feeds on brown algae, it converts a carbohydrate called laminarin to glucose, which could be used as a renewable fuel source. However, to protect themselves from sea slugs and other herbivores, the brown algae produce a secondary metabolite called phlorotannin that blocks this digestion, hindering the potential application of brown algae as feedstocks for biofuel.
“The enzyme responsible for laminin breakdown in the sea slug is called akuBGL, and it is blocked by phlorotannin. To counteract this antipredator adaptation of the brown algae, herbivores produce a substance in their digestive system called EHEP that protects from phlorotannins,” explains co-first author Xiaomei Sun, Postdoctor at the Faculty of Advanced Life Science, Hokkaido University, Japan. “Although this defence-antidefence strategy is known, the detailed molecular mechanism underlying it remains unclear.”
“With our study, we sought to understand the mechanism of this process, to benefit the application of this brown alga feeding system to the biofuel industry,” adds co-first author Yuxin Ye, Postdoctor at the Faculty of Advanced Life Science, Hokkaido University.
As it is challenging to isolate distinct chemicals from phlorotannins found in algae, the researchers used an analogue called TNA to explore its interaction with the sea slug’s akuBGL enzyme and EHEP protein. They used X-ray crystallography and computer simulations to determine the structure of EHEP, with and without TNA and akuBGL. Then they used the akuBGL structure to construct models of the enzyme and simulated the binding of both normal substrate (laminarin carbohydrate) and TNA. By exploring the interaction of TNA and the akuBGL enzyme with and without EHEP, they were able to propose a molecular mechanism of phlorotannin inhibition of akuBGL and of how EHEP protects against this.
In the absence of EHEP, phlorotannin occupies the substrate-binding pocket within akuBGL, preventing laminarin from binding and stopping glucose production. When EHEP is present it competitively binds to phlorotannin, freeing up the akuBGL binding pocket for glucose metabolism to happen as normal.
“Our study presents the molecular mechanism of the digestive-defencive-offencive association between brown algae and its herbivore predator, the sea slug,” concludes senior author Min Yao, Emeritus Professor at the Faculty of Advanced Life Science, Hokkaido University. “This provides a molecular basis for the biofuel industry applications of brown algae.”
eLife transforms research communication to create a future where a diverse, global community of scientists and researchers produces open and trusted results for the benefit of all. Independent, not-for-profit and supported by funders, we improve the way science is practised and shared. In support of our goal, we have launched a new publishing model that ends the accept/reject decision after peer review. Instead, papers invited for review will be published as a Reviewed Preprint that contains public peer reviews and an eLife assessment. We also continue to publish research that was accepted after peer review as part of our traditional process. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.
To read the latest Structural Biology and Molecular Biophysics research published in eLife, visit https://elifesciences.org/subjects/structural-biology-molecular-biophysics.